| 000 | 01682 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515220545.0 | ||
| 264 | 0 | _c20100518 | |
| 008 | 201005s 0 0 jpn d | ||
| 022 | _a0485-1439 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMimura, Naoya | |
| 245 | 0 | 0 |
_a[Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab]. _h[electronic resource] |
| 260 |
_b[Rinsho ketsueki] The Japanese journal of clinical hematology _cMar 2010 |
||
| 300 |
_a213-5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCarrier State _xvirology |
| 650 | 0 | 4 |
_aDNA, Viral _xanalysis |
| 650 | 0 | 4 |
_aGuanine _xadministration & dosage |
| 650 | 0 | 4 |
_aHepatitis B _xdiagnosis |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMonitoring, Physiologic |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aVirus Activation |
| 700 | 1 | _aKojima, Hiroshige | |
| 700 | 1 | _aTsujimura, Hideki | |
| 700 | 1 | _aIse, Mikiko | |
| 700 | 1 | _aSakai, Chikara | |
| 700 | 1 | _aFukai, Kenichi | |
| 700 | 1 | _aYokosuka, Osamu | |
| 700 | 1 | _aKumagai, Kyoya | |
| 773 | 0 |
_t[Rinsho ketsueki] The Japanese journal of clinical hematology _gvol. 51 _gno. 3 _gp. 213-5 |
|
| 999 |
_c19738419 _d19738419 |
||